Etanercept Plus UVB-311nm Phototherapy in Psoriasis

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

August 31, 2006

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
Psoriasis
Interventions
RADIATION

UVB-311nm radiation

UVB-311nm radiation randomized to one body half given 3 times a week for 6 weeks; the other body half remains UV-non-irradiated.

OTHER

No treatment

no UV exposure

Trial Locations (1)

A-8036

Medical University of Graz, Department of Dermatology, Graz

All Listed Sponsors
lead

Medical University of Graz

OTHER

NCT00550030 - Etanercept Plus UVB-311nm Phototherapy in Psoriasis | Biotech Hunter | Biotech Hunter